Tsai Chen Lung's Form 4/A amendment
AmendedCapsoVision, Inc (CV) · filed Feb 6, 2026
- Accession no.
- 0001307275-26-000002
- Filed
- Feb 6, 2026
- Trade date
- Jul 3, 2025
- Filing delay
- 218 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 3, 2025
This filing lists 1 non-derivative transaction. It carries over 5 transactions from the original filing that it did not restate. Open-market purchases total $83.4. It was filed 218 days after the trade.
This amendment restates part of 0000950170-25-094309 (filed Jul 7, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tsai Chen LungCIK 0001307275 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Common Stock | PPurchaseAcquired | +20 | $4.17 | +$83.4 | 20 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000950170-25-094309 (filed Jul 7, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Common Stock | CConversionAcquired | +91,432 | –F1 | – | 115,456 | Indirect |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Common Stock | CConversionDisposed | −21,450 | $0.00 | $0 | 0 | Indirect | |
| Jul 3, 2025 | Common Stock | CConversionDisposed | −16,683 | $0.00 | $0 | 0 | Indirect | |
| Jul 3, 2025 | Common Stock | CConversionDisposed | −26,112 | $0.00 | $0 | 0 | Indirect | |
| Jul 3, 2025 | Common Stock | CConversionDisposed | −27,187 | $0.00 | $0 | 0 | Indirect |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Held by the Reporting Person and his wife in a joint brokerage account. The transaction was inadvertently omitted from the original Form 4 filed on July 7, 2025.